Actinogen Medical Future Growth
Future criteria checks 0/6
Actinogen Medical's revenue and earnings are forecast to decline at 1% and 78.4% per annum respectively while EPS is expected to decline by 70.1% per annum.
Key information
-78.4%
Earnings growth rate
-70.1%
EPS growth rate
Biotechs earnings growth | 23.5% |
Revenue growth rate | -1.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 22 Dec 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2025 | 5 | -61 | -61 | N/A | 1 |
6/30/2024 | 4 | -24 | -24 | N/A | 1 |
6/30/2023 | 5 | -11 | -9 | -9 | N/A |
3/31/2023 | 5 | -11 | -9 | -9 | N/A |
12/31/2022 | 5 | -11 | -9 | -9 | N/A |
9/30/2022 | 4 | -10 | -9 | -9 | N/A |
6/30/2022 | 4 | -9 | -10 | -10 | N/A |
3/31/2022 | 3 | -8 | -8 | -8 | N/A |
12/31/2021 | 2 | -7 | -6 | -6 | N/A |
9/30/2021 | 2 | -6 | -4 | -4 | N/A |
6/30/2021 | 2 | -4 | -2 | -2 | N/A |
3/31/2021 | 2 | -4 | -2 | -2 | N/A |
12/31/2020 | 3 | -4 | -2 | -2 | N/A |
9/30/2020 | 3 | -4 | -3 | -3 | N/A |
6/30/2020 | 4 | -5 | -3 | -3 | N/A |
3/31/2020 | 5 | -6 | -5 | -5 | N/A |
12/31/2019 | 6 | -7 | -7 | -7 | N/A |
9/30/2019 | 5 | -8 | -9 | -9 | N/A |
6/30/2019 | 5 | -10 | -10 | -10 | N/A |
3/31/2019 | 4 | -10 | -10 | -10 | N/A |
12/31/2018 | 3 | -10 | -9 | -9 | N/A |
9/30/2018 | 3 | -8 | -8 | -8 | N/A |
6/30/2018 | 3 | -6 | -8 | -8 | N/A |
3/31/2018 | 2 | -6 | -6 | -6 | N/A |
12/31/2017 | 2 | -5 | -4 | -4 | N/A |
9/30/2017 | 1 | -4 | -3 | -3 | N/A |
6/30/2017 | 1 | -3 | -1 | -1 | N/A |
3/31/2017 | 2 | -4 | N/A | -2 | N/A |
12/31/2016 | 3 | -4 | N/A | -2 | N/A |
9/30/2016 | 3 | -4 | N/A | -4 | N/A |
6/30/2016 | 4 | -4 | N/A | -5 | N/A |
3/31/2016 | 3 | -5 | N/A | -5 | N/A |
12/31/2015 | 1 | -5 | N/A | -5 | N/A |
9/30/2015 | 1 | -5 | N/A | -4 | N/A |
6/30/2015 | 0 | -5 | N/A | -4 | N/A |
3/31/2015 | 0 | -3 | N/A | -2 | N/A |
12/31/2014 | 0 | -2 | N/A | -1 | N/A |
9/30/2014 | 0 | -1 | N/A | -1 | N/A |
6/30/2014 | 0 | 0 | N/A | 0 | N/A |
3/31/2014 | 0 | 0 | N/A | 0 | N/A |
12/31/2013 | 0 | 0 | N/A | 0 | N/A |
9/30/2013 | 0 | 0 | N/A | 0 | N/A |
6/30/2013 | 0 | 0 | N/A | 0 | N/A |
3/31/2013 | 0 | 0 | N/A | 0 | N/A |
12/31/2012 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ATGG.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ATGG.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ATGG.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ATGG.F's revenue is expected to decline over the next 3 years (-1% per year).
High Growth Revenue: ATGG.F's revenue is forecast to decline over the next 3 years (-1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ATGG.F's Return on Equity is forecast to be high in 3 years time